Patent applications and USPTO patent grants for KADMON CORPORATION, LLC.The latest application filed is for "inhibitors of rho associated coiled-coil containing protein kinase".
Patent | Date |
---|---|
Treatment of GVHD Grant 11,311,541 - Zanin-Zhorov , et al. April 26, 2 | 2022-04-26 |
Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors Grant 11,071,735 - Kim , et al. July 27, 2 | 2021-07-27 |
Inhibitors Of Rho Associated Coiled-coil Containing Protein Kinase App 20210163421 - Skucas; Eduardas ;   et al. | 2021-06-03 |
Rho Kinase Inhibitors App 20210147391 - Poyurovsky; Masha V. ;   et al. | 2021-05-20 |
Glucose uptake inhibitors Grant 10,988,484 - Olszewski , et al. April 27, 2 | 2021-04-27 |
Immunomodulatory Agents App 20210022773 - Waksal; Samuel D. ;   et al. | 2021-01-28 |
Human Anti-vegfr-2/kdr Antibodies App 20200246456 - Kind Code | 2020-08-06 |
Treatment of infectious diseases with glucose uptake inhibitors Grant 10,729,691 - Olszewski , et al. | 2020-08-04 |
Rho kinase inhibitors Grant 10,696,660 - Poyurovsky , et al. June 30, 2 | 2020-06-30 |
Inhibitors of RHO Associated Coiled-Coil Containing Protein Kinase App 20200199109 - Skucas; Eduardas ;   et al. | 2020-06-25 |
Inhibitors Of Rho Associated Coiled-coil Containing Protein Kinase App 20200165206 - Skucas; Eduardas ;   et al. | 2020-05-28 |
Human anti-VEGFR-2/KDR antibodies Grant 10,588,968 - Lu , et al. | 2020-03-17 |
Treatment Of Inflammatory Conditions And Autoimmune Diseases With Glucose Uptake Inhibitors App 20200046702 - Kim; Ji-In ;   et al. | 2020-02-13 |
Glucose Uptake Inhibitors App 20190315772 - Olszewski; Kellen L. ;   et al. | 2019-10-17 |
Rho Kinase Inhibitors App 20190308953 - Poyurovsky; Masha V. ;   et al. | 2019-10-10 |
Immunomodulatory agents Grant 10,407,502 - Waksal , et al. Sept | 2019-09-10 |
Human anti-VEGFR-2/KDR antibodies Grant 10,364,291 - Zhu , et al. | 2019-07-30 |
Glucose uptake inhibitors Grant 10,273,248 - Olszewski , et al. | 2019-04-30 |
Treatment Of Infectious Diseases With Glucose Uptake Inhibitors App 20190060314 - Olszewski; Kellen ;   et al. | 2019-02-28 |
Rho kinase inhibitors Grant 10,183,931 - Poyurovsky , et al. Ja | 2019-01-22 |
Rho kinase inhibitors Grant 10,125,144 - Kim , et al. November 13, 2 | 2018-11-13 |
Glucose Uptake Inhibitors App 20180298029 - Olszewski; Kellen ;   et al. | 2018-10-18 |
Treatment of brain and central nervous system tumors Grant 10,080,752 - Waksal September 25, 2 | 2018-09-25 |
Human Anti-vegfr-2/kdr Antibodies App 20180250392 - Lu; Dan ;   et al. | 2018-09-06 |
Immunomodulatory Agents App 20180244779 - Lu; Dan ;   et al. | 2018-08-30 |
Rho Kinase Inhibitors App 20180244657 - Poyurovsky; Masha ;   et al. | 2018-08-30 |
Human anti-VEGFR-2/KDR antibodies Grant 10,023,640 - Zhu , et al. July 17, 2 | 2018-07-17 |
Rho kinase inhibitors Grant 9,815,820 - Poyurovsky , et al. November 14, 2 | 2017-11-14 |
Treatment Of Gvhd App 20170112832 - ZANIN-ZHOROV; Alexandra ;   et al. | 2017-04-27 |
Treatment Of Brain And Central Nervous System Tumors App 20170071943 - WAKSAL; Samuel | 2017-03-16 |
Methods for treatment of breast cancer nonresponsive to trastuzumab Grant 9,586,940 - Waksal , et al. March 7, 2 | 2017-03-07 |
Immunomodulatory Agents App 20160340429 - WAKSAL; Samuel ;   et al. | 2016-11-24 |
Methods And Compositions For Oral Delivery Of Fts App 20160271089 - Bauer; Victor J. | 2016-09-22 |
Rho Kinase Inhibitors App 20160237095 - KIM; Ji-in ;   et al. | 2016-08-18 |
Methods For Treatment Of Breast Cancer Nonresponsive To Trastuzumab App 20150322046 - Waksal; Samuel ;   et al. | 2015-11-12 |
Human Anti-vegfr-2/kdr Antibodies App 20150284464 - Zhu; Zhenping ;   et al. | 2015-10-08 |
Treatment Of Ocular Disorders App 20150238601 - Boxer; Michael A. ;   et al. | 2015-08-27 |
Methods For Treatment Of Breast Cancer Nonresponsive To Trastuzumab App 20150010545 - Waksal; Samuel ;   et al. | 2015-01-08 |
Inhibitors Of Mtor Kinase As Anti -viral Agent App 20140206678 - Shenk; Thomas ;   et al. | 2014-07-24 |
Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer Grant 8,338,481 - Kloog , et al. December 25, 2 | 2012-12-25 |
NCAGE Code | 6ALL0 | KADMON CORPORATION, LLC!DBA KADMON |
NCAGE Code | 77HL0 | KADMON CORPORATION, LLC!DBA USE CAGE CODE 6ALL0 FOR!CATALOGING |
CAGE Code | 77HL0 | KADMON CORPORATION, LLC USE CAGE CODE 6ALL0 FOR CATALOGING |
CAGE Code | 6ALL0 | KADMON CORPORATION, LLC KADMON |
S.A.M. Registration | 6ALL0 [962923947] | KADMON CORPORATION, LLC KADMON |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.